|
PPM1D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32109999998009E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.916800E-03 |
| Normal-vs-Stage2 |
3.167500E-02 |
| Normal-vs-Stage3 |
1.724340E-02 |
| Normal-vs-Stage4 |
3.519200E-01 |
| Stage1-vs-Stage2 |
2.730600E-01 |
| Stage1-vs-Stage3 |
2.615800E-01 |
| Stage1-vs-Stage4 |
4.959000E-01 |
| Stage2-vs-Stage3 |
9.252400E-01 |
| Stage2-vs-Stage4 |
6.743400E-01 |
| Stage3-vs-Stage4 |
6.538400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.62840000001086E-06 |
| Normal-vs-AfricanAmerican |
2.418100E-02 |
| Normal-vs-Asian |
2.020400E-01 |
| Caucasian-vs-AfricanAmerican |
5.787000E-01 |
| Caucasian-vs-Asian |
8.855200E-01 |
| AfricanAmerican-vs-Asian |
7.250400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.68239999999554E-05 |
| Normal-vs-Female |
8.34880000000204E-05 |
| Male-vs-Female |
1.488350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.472100E-02 |
| Normal-vs-Extreme_Weight |
5.634000E-02 |
| Normal-vs-Obese |
5.143700E-03 |
| Normal-vs-Extreme_Obese |
2.697800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.958600E-01 |
| Normal_Weight-vs-Obese |
9.507800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.826200E-01 |
| Extreme_Weight-vs-Obese |
1.906550E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.178000E-01 |
| Obese-vs-Extreme_Obese |
9.356400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.444800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.45439999996466E-06 |
| Normal-vs-Age(61-80Yrs) |
5.319800E-03 |
| Normal-vs-Age(81-100Yrs) |
8.425200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.107000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.365600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.300300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.980320E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.335100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.614400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.37720000029596E-07 |
| Normal-VS-Type2 PRCC |
1.706410E-01 |
| Normal-VS-KIRP CIMP |
1.127930E-02 |
| Normal-VS-Unclassified PRCC |
1.641660E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.139200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.534500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.146200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.008000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.785800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.844800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.048180E-01 |
| Normal-vs-N1 |
2.957800E-02 |
| Normal-vs-N2 |
8.759400E-01 |
| N0-vs-N1 |
9.523600E-02 |
| N0-vs-N2 |
7.488400E-01 |
| N1-vs-N2 |
3.984600E-01 |
|
|
